Clinical trialNCT01843062TerminatedPhase 3Interventional

Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer

SponsorAstraZenecaEnrollment233Differentiated Thyroid Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alan Ho, M.D., PHD
Memorial Sloan Kettering Cancer Centre, 1275 York Avenue, New York, NY 10065.
Principal Investigator
clinicaltrials.gov ↗
Tracy C Cunningham, M.D
Melbourn Science Park, Cambridge Road, Melbourn, Hertfordshire, SG8 6HB, UK
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil

Research Site
Barretos, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Ribeirão Preto, Brazil
Research Site
Rio de Janeiro, Brazil
Research Site
São José do Rio Preto, Brazil
Research Site
São Paulo, Brazil

Denmark

Research Site
Odense C, Denmark

France

Research Site
Angers, France
Research Site
Bordeaux, France
Research Site
Caen, France
Research Site
Lyon, France
Research Site
Toulouse, France
Research Site
Villejuif, France

Germany

Research Site
Augsburg, Germany
Research Site
Essen, Germany
Research Site
Leipzig, Germany

Italy

Research Site
Catania, Italy
Research Site
Naples, Italy
Research Site
Pisa, Italy
Research Site
Roma, Italy

Poland

Research Site
Gliwice, Poland
Research Site
Kielce, Poland
Research Site
Poznan, Poland
Research Site
Warsaw, Poland
Research Site
Warsaw, Poland
Research Site
Zgierz, Poland

Sweden

Research Site
Gothenburg, Sweden
Research Site
Linköping, Sweden
Research Site
Lund, Sweden
Research Site
Stockholm, Sweden

United States

Research Site
Birmingham, Alabama, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Los Angeles, California, United States
Research Site
Torrance, California, United States
Research Site
Aurora, Colorado, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Boston, Massachusetts, United States
Research Site
Boston, Massachusetts, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States

5 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Aug 2013
Primary completion: 18 May 2018
Completion: 6 Mar 2019
Last update posted: 28 Aug 2019
Registered enrollment: 233
Registry id: NCT01843062

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-000423-14

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.